- Modules
- module-menu-test
- Table of Contents
- Resource Overview
- Module 1
- Lesson 2: 1/11- Learning Outcome
- Lesson 2: 10/11 – Summary
- Lesson 2: 11/11 – Learning Activities and Reflection
- Lesson 2: 2/11 – Introduction
- Lesson 2: 3/11 – Regulation of Nursing Practice in Canada
- Lesson 2: 4/11 – Provincial and Territorial Regulatory Resources for CDS (1/2) _
- Lesson 2: 5/11 – Provincial and Territorial Regulatory Resources for CDS (2/2)
- Lesson 2: 6/11 – Maintenance of Professional Competence
- Lesson 2: 7/11 – Learning activities for continuing competence related to CDS prescribing
- Lesson 2: 8/11 – Protection of Personal Health Information
- Lesson 2: 9/11 – Learning Activity concerning Protection of Personal Health Information
- Lesson 3: 1/7 – Learning Outcome
- Lesson 3: 2/7 – Introduction
- Lesson 3: 3/7 – Prescription Monitoring Programs (1/2) __
- Lesson 3: 4/7 – Prescription Monitoring Systems (2/2) __
- Lesson 3: 5/7 – Prescription Monitoring Programs across Canada
- Lesson 3: 6/7 – Summary
- Lesson 3: 7/7 – Activities and Reflections
- Lesson 4: 1/25 – Learning Outcome
- Lesson 4: 10/25 – Documentation and Record Keeping Exercise
- Lesson 4: 11/25 – Reporting of Adverse Events to Increase Prescription Safety
- Lesson 4: 12/25 – Disposal of Unused or Expired Medications to Increase Safety
- Lesson 4: 13/25 – Storage and Transportation of CDS Approach to Increase Safety
- Lesson 4: 14/25 – Storage and Transportation of CDS Exercise
- Lesson 4: 15/25 – Practice Toolkits to Increase Safety
- Lesson 4: 16/25 – Addiction Risk Assessment Approach to Safety
- Lesson 4: 17/25 – Pain Assessment Tools
- Lesson 4: 18/25 – Treatment Agreements to Increase Prescription Safety
- Lesson 4: 19/25 – Treatment Agreements Exercise
- Lesson 4: 2/25 – Introduction
- Lesson 4: 20/25 – Urine Drug Testing to Increase Prescription Safety
- Lesson 4: 21/25 – Urine Drug Testing Exercise
- Lesson 4: 22/25 – Jurisdictional Pain Strategies Exercise
- Lesson 4: 23/25 – Resources for Pain Management
- Lesson 4: 24/25 – Summary
- Lesson 4: 25/25 – Learning Activity and Reflection
- Lesson 4: 3/25 – Drug Databases
- Lesson 4: 4/25 – Health Canada Drug Product Database Exercise
- Lesson 4: 5/25 – Safety Principles for Prescribing
- Lesson 4: 6/25 – Application of Universal Precaution to Increase Safety
- Lesson 4: 7/25 – Anti-drug strategy to increase safety
- Lesson 4: 8/25 – Anti-drug exercise
- Lesson 4: 9/25 – Record Keeping to Increase Prescription Safety
- Lesson 5: 1/22 – Learning Outcome
- Lesson 5: 10/22 Step 4: Appraise/Critique
- Lesson 5: 11/22 – Step 5: Synthesize
- Lesson 5: 12/22 – About Clinical Practice Guidelines (CPGs)
- Lesson 5: 13/22 – Definition of Clinical Practice Guidelines (CPGs)
- Lesson 5: 14/22 – Quality of Clinical Practice Guidelines (CPGs)
- Lesson 5: 15/22 – Using CPGs in Practice
- Lesson 5: 16/22 – Guideline Development
- Lesson 5: 17/22 – Critical Appraisal of Clinical Practice Guidelines (CPGs): Key Components
- Lesson 5: 18/22 – Case Study – Laureen’s Story
- Lesson 5: 19/22 – Laureen – A Case Study Learning Activity
- Lesson 5: 2/22 – Introduction
- Lesson 5: 20/22 – Exercise
- Lesson 5: 21/22 – Synthesizing and Applying the CPG to the Clinical Case Study
- Lesson 5: 22/22 – Summary
- Lesson 5: 3/22 – The evolving journey from Evidence-BASED practice to Evidence-INFORMED practice
- Lesson 5: 4/22 – Evidence-BASED practice to Evidence-INFORMED practice
- Lesson 5: 5/22 – Types of Credible Research and the Uniqueness of Substance Abuse and Misuse Evidence
- Lesson 5: 6/22 – Steps to Evidence-informed Practice
- Lesson 5: 7/22 – Step 1: Define
- Lesson 5: 8/22 – Step 2: Search
- Lesson 5: 9/22 – Step 3: Verify Credibility
- Lesson 6: 1/23 – Learning Outcomes
- Lesson 6: 10/23 – Application of The Four Topic Approach in CDS Prescribing
- Lesson 6: 11/23 – Principles of The Four Topic Approach
- Lesson 6: 12/23 – Reading
- Lesson 6: 13/23 – Four Topics Approach to Clinical Ethics
- Lesson 6: 14/23 – Application of the Four Topic Framework
- Lesson 6: 15/23 – Medical Indications
- Lesson 6: 16/23 – Treatment Collaboration
- Lesson 6: 17/23 – Patient Preferences
- Lesson 6: 18/23 – Respecting Patient Autonomy
- Lesson 6: 19/23 – Quality of Life
- Lesson 6: 2/23 – The Story of SM
- Lesson 6: 20/23 – Contextual Features
- Lesson 6: 21/23 – After the four topics
- Lesson 6: 22/23 – Resolution of the Four Topics Approach
- Lesson 6: 23/23 – Summary
- Lesson 6: 3/23 – Introduction
- Lesson 6: 4/23 – Learning Activity – Ethical Considerations related to CDS
- Lesson 6: 5/23 – Reflective Questions
- Lesson 6: 6/23 – Moral Values
- Lesson 6: 7/23 – Exercise: Truth or Myth?
- Lesson 6: 8/23 – Stigma Exercise
- Lesson 6: 9/23 – Clinical Ethics: The Four Topic Approach
- Module 1 – Introduction
- Module 1 – Lesson 1 – Appendix B
- Module 1 – Lesson 5 – Appendix A
- Module 1 – Learning Outcomes
- Modules intro
- Lesson 1 – 1/15 – Learning Outcome
- Lesson 1 – 2/15 – Federal Legislation and Regulation
- Lesson 1: 3/15 – The Controlled Drugs and Substances Act (1/3) __
- Lesson 1: 13/15 – Provincial Legislation and Regulations (2/2) __
- Lesson 1: 4/15 – The Controlled Drugs and Substances Act (2/3) __
- Lesson 1: 5/15 – The Controlled Drugs and Substances Act (3/3) __
- Lesson 1: 6/15 – The New Classes of Practitioners Regulations (1/3) __
- Lesson 1: 7/15 – The New Classes of Practitioners Regulations (2/3) __
- Lesson 1: 8/15 – The New Classes of Practitioners Regulations (3/3) __
- Lesson 1: 9/15 The Narcotic Control Regulations
- Lesson 1: 10/15 The Benzodiazepines and Other Targeted Substances Regulations (BOTSR)
- Lesson 1: 11/15 – The Food and Drug Regulations
- Lesson 1: 12/15 – Provincial Legislation and Regulations (1/2) __
- Lesson 1: 14/15 – Summary
- Lesson 1: 15/15 – Learning Activities and Reflection
- Module 2
- Lesson 1: 1/44 – Learning Outcome
- Lesson 1: 10/44 – Pharmacokinetics of Opioids
- Lesson 1: 11/44 – Opioids – Common indications and dosages (1/2) __
- Lesson 1: 12/44 – Opioids – Common Indications and Dosages (2/2) _
- Lesson 1: 13/44 – Opioids – General Approaches to Management
- Lesson 1: 14/44 – Opioids – Common adverse effects
- Lesson 1: 15/44 – Opioids – Contraindications/Precautions
- Lesson 1: 16/44 – Benzodiazepines
- Lesson 1: 17/44 – Benzodiazepines – Pharmacodynamics
- Lesson 1: 18/44 – Benzodiazepines – Pharmacokinetics (1/2) _
- Lesson 1: 19/44 – BENZODIAZEPINES – Pharmacokinetics (2/2) _
- Lesson 1: 2/44 – Introduction
- Lesson 1: 20/44 – Benzodiazepines – Common Indications and Dosages
- Lesson 1: 21/44 – Benzodiazepines – General Approaches to Management
- Lesson 1: 22/44 – Benzodiazepines – Common adverse effects
- Lesson 1: 23/44 – Benzodiazepines – Precautions
- Lesson 1: 24/44 – BARBITURATES
- Lesson 1: 25/44 – Barbiturates – Pharmacodynamics / mechanism of action
- Lesson 1: 26/44 – Barbiturates – Pharmacokinetics (1/2) _
- Lesson 1: 27/44 – Barbiturates – Pharmacokinetics (2/2) _
- Lesson 1: 28/44 – Barbiturates – Indications (1/2) _
- Lesson 1: 29/44 – Barbiturates – Indications (2/2) _
- Lesson 1: 3/44 – Some Basic Definitions (1/2) _
- Lesson 1: 30/44 – Barbiturates – Common adverse effects
- Lesson 1: 31/44 – Barbiturates – Precautions
- Lesson 1: 32/44 – Psychostimulants / amphetamines
- Lesson 1: 33/44 – Psychostimulants/amphetamines – Pharmacodynamics
- Lesson 1: 34/44 – Psychostimulants / amphetamines – Pharmacokinetics (1/2) _
- Lesson 1: 35/44 – Psychostimulants / amphetamines – Pharmacokinetics (2/2) _
- Lesson 1: 36/44 – Psychostimulants / amphetamines – Indications (1/2) _
- Lesson 1: 37/44 – Psychostimulants/amphetamines – Indications (2/2) _
- Lesson 1: 38/44 – Psychostimulants/amphetamines – Common adverse effects
- Lesson 1: 39/44 – Anabolic steroids
- Lesson 1: 4/44 – Some Basic Definitions (2/2) __
- Lesson 1: 40/44 – Anabolic steroids – Pharmacodynamics/mechanism of action
- Lesson 1: 41/44 – Anabolic steroids – Pharmacokinetics
- Lesson 1: 42/44 – Anabolic steroids – Indications and dosage
- Lesson 1: 43/44 – Anabolic steroids – Precautions
- Lesson 1: 44/44 – Summary
- Lesson 1: 5/44 – Learning Activity
- Lesson 1: 6/44 – Opioids
- Lesson 1: 7/44 – Opioids – Pharmacodynamics (1/2) _
- Lesson 1: 8/44 -Opioids – Pharmacodynamics (2/2) __
- Lesson 1: 9/44 – Opioids – Pharmacokinetics
- Lesson 2: 1/18 – Learning Outcome
- Lesson 2: 10/18 – Buprenorphine and buprenorphine/naloxone (3/3) __
- Lesson 2: 11/18 – Cannabinoids
- Lesson 2: 12/18 – Cannabinoids – Regulatory Considerations for Prescribing
- Lesson 2: 13/18 – Cannabinoids – Pharmacodynamics/mechanism of action
- Lesson 2: 14/18 – Cannabinoids – Pharmacokinetics
- Lesson 2: 15/18 – Cannabinoids – Common indications and dosages
- Lesson 2: 16/18 – Cannabinoids – Adverse reactions and management
- Lesson 2: 17/18 – Cannabinoids – Precautions
- Lesson 2: 18/18 – Cannabinoids – Learning activities
- Lesson 2: 2/18 – Methadone
- Lesson 2: 3/18 – Methadone – Special exemptions for prescribing
- Lesson 2: 4/18 – Methadone – Pharmacodynamics / mechanism of action
- Lesson 2: 5/18 – Methadone – Pharmacokinetics
- Lesson 2: 6/18 – Methadone – Indications
- Lesson 2: 7/18 – Methadone – Precautions
- Lesson 2: 8/18 Buprenorphine and Buprenorphine/Naloxone (1/3) _
- Lesson 2: 9/18 – Buprenorphine and buprenorphine/naloxone (2/3) __
- Lesson 3: 1/5 – Learning Outcome
- Lesson 3: 2/5 – Other agents – Z-drugs
- Lesson 3: 3/5 – Other agents – Gabapentinoids
- Lesson 3: 4/5 – Other agents – Tramadol
- Lesson 3: 5/5 – Summary
- Lesson 4: 1/9 – Learning Outcome
- Lesson 4: 2/9 – Introduction
- Lesson 4: 3/9 – Opioid Rotation
- Lesson 4: 4/9 – Opioid Rotation – Oral Opioid Dosage Conversion Table
- Lesson 4: 5/9 – Opioid Rotation – Opioid Equivalency Calculators
- Lesson 4: 6/9 – Opioid Rotation – Learning Activities
- Lesson 4: 7/9 – Adjusting Benzodiazepine Doses
- Lesson 4: 8/9 – Creating a Safe Environment for Prescribing
- Lesson 4: 9/9 – Summary
- Lesson 5: 1/9 – Learning Outcome
- Lesson 5: 2/9 – Introduction
- Lesson 5: 3/9 – Psychosocial Influences (1/2) _
- Lesson 5: 4/9 – Psychosocial Influences (2/2) _
- Lesson 5: 5/9 – Cultural and ethnic variables
- Lesson 5: 6/9 – Genetic Influences
- Lesson 5: 7/9 – Gender influences
- Lesson 5: 8/9 – Patient Teaching
- Lesson 5: 9/9 – Summary
- Module 2 – Learning Outcomes
- Module 2 – Introduction
- Module 3
- Lesson 4: 1/8 – Learning Outcome
- Module 3 – Introduction
- Lesson 1: 1/12 – Learning Outcome
- Lesson 1: 2/12 – Definition of Chronic Pain
- Lesson 1: 3/12 – Epidemiology of chronic pain
- Lesson 1: 4/12 – Chronic Pain: Need for Opioid Therapy
- Lesson 1: 5/12 – Chronic Pain: Comprehensive Assessment (1/5) _
- Lesson 1: 6/12 – Chronic Pain: Comprehensive Assessment (2/5) __
- Lesson 1: 7/12 – Chronic Pain: Comprehensive Assessment (3/5) __
- Lesson 1: 8/12 – Chronic Pain: Comprehensive Assessment (4/5) __
- Lesson 1: 9/12 – Chronic Pain: Comprehensive Assessment (5/5) __
- Lesson 1: 10/12 – Chronic Pain: Safety Considerations
- Lesson 1: 11/12 – Chronic Pain: Goals of Care
- Lesson 1: 12/12 – Summary
- Lesson 2: 1/12 – Learning Outcome
- Lesson 2: 2/12 – Epidemiology of Acute Pain
- Lesson 2: 3/12– Acute Pain: Need for Opioid Therapy
- Lesson 2: 4/12 – Acute Pain: Comprehensive Assessment (1/5) __
- Lesson 2: 5/12 – Acute Pain: Comprehensive Assessment (2/5) __
- Lesson 2: 6/12 – Acute Pain: Comprehensive Assessment (3/5) __
- Lesson 2: 7/12 – Acute Pain: Comprehensive Pain Assessment (4/5) __
- Lesson 2: 8/12 – Acute Pain: Comprehensive Assessment (5/5) __
- Lesson 2: 9/12 – Acute Pain: Safety Considerations
- Lesson 2: 10/12 – Acute Pain: Goals of Care
- Lesson 2: 11/12 – Comprehensive Assessment of Acute Pain in Children
- Lesson 2: 12/12 – Comprehensive Assessment of Acute Pain in Older Adults
- Lesson 3: 1/7 – Learning Outcome
- Lesson 3: 2/7 – Definition of Insomnia
- Lesson 3: 3/7 – Insomnia: Symptom Assessment
- Lesson 3: 4/7 – Physical Examination
- Lesson 3: 5/7 – Standard Assessment Tools
- Lesson 3: 6/7 – Safety Considerations
- Lesson 3: 7/7 – Goals of Care
- Lesson 4: 2/8 – Epidemiology of ADHD
- Lesson 4: 3/8 – ADHD: Comprehensive Assessment (1/4) __
- Lesson 4: 4/8 – ADHD: Comprehensive Assessment (2/4) __
- Lesson 4: 5/8 ADHD: Comprehensive Assessment (3/4) __
- Lesson 4: 6/8 – ADHD: Comprehensive Assessment (4/4) __
- Lesson 4: 7/8 – ADHD: Safety Considerations
- Lesson 4: 8/8 – ADHD: Goals of Care
- Lesson 5: 1/13 – Learning Outcome
- Lesson 5: 2/13 – Symptoms of Anxiety
- Lesson 5: 3/13 – Anxiety Disorders
- Lesson 5: 4/13 – Assessment, Diagnosis, and Management of Anxiety
- Lesson 5: 5/13 – Epidemiology of Anxiety Disorders
- Lesson 5: 6/13 – Anxiety: Need for CDS & Comprehensive Assessment (1/5) __
- Lesson 5: 7/13 – Anxiety: Comprehensive Assessment (2/5) __
- Lesson 5: 8/13 – Anxiety: Comprehensive Assessment (3/5) __
- Lesson 5: 10/13 – Anxiety: Comprehensive Assessment (5/5) __
- Lesson 5: 9/13 – Anxiety: Comprehensive Assessment (4/5) __
- Lesson 5: 11/13 – Anxiety: Safety Considerations
- Lesson 5: 12/13 – Anxiety: Goals of Care
- Lesson 5: 13/13 – Other Considerations: Post-Traumatic Stress Disorder (PTSD)
- Lesson 6: 1/6 – Learning Outcome
- Lesson 6: 2/6 – Epidemiology of Status Epilepticus
- Lesson 6: 3/6 – Status Epilepticus: Comprehensive Assessment (1/2) __
- Lesson 6: 4/6 – Status Epilepticus: Comprehensive Assessment (2/2) __
- Lesson 6: 5/6 – Status Epilepticus: Safety Considerations
- Lesson 6: 6/6 – Status Epilepticus: Goals of Care
- Module 4
- Lesson 2: 10/13 — Equianalgesia
- Lesson 2: 11/13 — Pediatric dosing of opioids
- Lesson 2: 12/13 — Choose the correct opioid formulation
- Lesson 2: 8/13 — Prescribing opioids (2/3) __
- Lesson 2: 9/13 — Prescribing opioids (3/3) __
- Lesson 4: 3/12 – Opioid tapering (2/3) __
- Lesson 4: 4/12 – Opioid tapering (3/3) __
- Module 4 – Introduction
- Lesson 1: 1/7 — Learning Outcome
- Lesson 1: 2/7 — Need for judicious CDS prescribing (1/5) __
- Lesson 1: 3/7 — Need for judicious CDS prescribing (2/5) __
- Lesson 1: 4/7 — Need for judicious CDS prescribing (3/5) __
- Lesson 1: 5/7 — Need for judicious CDS prescribing (4/5) __
- Lesson 1: 6/7 — Awareness of drug plan limits and exceptional access programs
- Lesson 1: 7/7 — Need for judicious CDS prescribing (5/5) __
- Lesson 2: 1/13 — Learning Outcome
- Lesson 2: 2/13 — Prescribing competency: self-assessment
- Lesson 2: 3/13 — Prior to CDS prescribing
- Lesson 2: 4/13 — Treatment agreements
- Lesson 2: 6/13 — Choosing the right medication and dose
- Lesson 2: 5/13 — Treatment agreement exercise
- Lesson 2: 7/13 — Prescribing opioids (1/3) __
- Lesson 2: 13/13 — Documents to review prior to prescribing an opioid
- Lesson 3: 1/4 — Learning Outcome
- Lesson 3: 2/4 – Outpatient prescriptions
- Lesson 3: 3/4 – In-patient prescriptions
- Lesson 3: 4/4 – Additional considerations
- Lesson 4: 1/12 — Learning Outcome
- Lesson 4: 2/12 – Opioid tapering (1/3) __
- Lesson 4: 5/12 – Benzodiazepines (1/3) __
- Lesson 4: 6/12 – Benzodiazepines (2/3) __
- Lesson 4: 7/12 — Benzodiazepines (3/3) __
- Lesson 4: 8/12 – Benzodiazepine rotation and tapering (1/2) __
- Lesson 4: 9/12 – Benzodiazepines rotating and tapering (2/2) __
- Lesson 4: 10/12 – Stimulants
- Lesson 4: 11/12 – Rotation and tapering of stimulant medications
- Lesson 4: 12/12 – Summary
- Module 5
- Lesson 3: 3/3 – Focused history and physical
- Lesson 4: 2/5 – Responding to prescription fraud
- Lesson 4: 3/5 – Prescription theft
- Module 5 – Introduction
- Lesson 1: 1/2 – Learning Outcome
- Lesson 1: 1/2 – Treatment evalution
- Lesson 2: 1/3 – Learning Outcome
- Lesson 2: 2/3 – Aberrant drug-related behaviour (1/2) __
- Lesson 2: 3/3 – Aberrant drug-related behaviour (2/2) __
- Lesson 3: 1/3 – Learning Outcome
- Lesson 3: 2/3 – Follow up activities
- Lesson 4: 1/5 – Learning Outcome
- Lesson 4: 4/5 – Referrals
- Lesson 4: 5/5 – Learning activities and reflection
